Literature DB >> 18475164

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.

Zhibin Li1, Björn Dahlöf, Peter M Okin, Sverre E Kjeldsen, Kristian Wachtell, Hans Ibsen, Markku S Nieminen, Sverker Jern, Richard B Devereux.   

Abstract

BACKGROUND: Whether left bundle branch block is associated with cardiovascular events in hypertension with electrocardiographic left ventricular hypertrophy is unknown.
METHODS: Hypertensive patients with electrocardiographic-left ventricular hypertrophy were randomized to losartan-based or atenolol-based treatment and followed for 4.8 years in the losartan intervention for endpoint reduction in hypertension study. Cox regression models controlling for significant covariates assessed the association of left bundle branch block with cardiovascular events.
RESULTS: At baseline, 564 patients had left bundle branch block and 8567 patients did not. Left bundle branch block was associated with higher heart rate, electrocardiographic-left ventricular hypertrophy, and prior cardiovascular disease (all P < 0.005). In univariate Cox regression analysis, left bundle branch block was not associated with the composite endpoint, stroke, or myocardial infarction (all P > 0.05), and was associated with cardiovascular (8.3 versus 4.5%, P < 0.001) and all-cause mortality (12.1 versus 8.6%, P < 0.005). After adjusting for significant covariates Cox regression analyses showed that left bundle branch block was independently associated with 1.6-fold more cardiovascular death (95% confidence interval 1.12-2.27, P < 0.05), 1.7 fold more hospitalization for heart failure (95% confidence interval 1.15-2.56, P < 0.01), 3.5 fold more cardiovascular death within 1 h (95% confidence interval 1.89-6.63, P < 0.001), and 3.4 fold more cardiovascular death within 24 h (95% confidence interval 1.83-6.35, P < 0.001).
CONCLUSION: In hypertension with electrocardiographic-left ventricular hypertrophy, left bundle branch block identifies patients at increased risk of cardiovascular mortality, sudden cardiovascular death, and heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475164     DOI: 10.1097/HJH.0b013e3282fcc23c

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Transcatheter aortic valve implantation-induced left bundle branch block: causes and consequences.

Authors:  Thomas T Poels; Patrick Houthuizen; Leen A F M Van Garsse; Jos G Maessen; Peter de Jaegere; Frits W Prinzen
Journal:  J Cardiovasc Transl Res       Date:  2014-05-07       Impact factor: 4.132

Review 2.  Cardiac arrhythmias in arterial hypertension.

Authors:  Dimitrios Varvarousis; Manolis Kallistratos; Leonidas Poulimenos; Andreas Triantafyllis; Pavlos Tsinivizov; Andreas Giannakopoulos; Konstantinos Kyfnidis; Athanasios Manolis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-09       Impact factor: 3.738

3.  Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension).

Authors:  Manuel A Gomez-Marcos; Rogelio Gonzalez-Sarmiento; José I Recio-Rodríguez; Cristina Agudo-Conde; Luis Gamella-Pozuelo; Nuria Perretta-Tejedor; Carlos Martínez-Salgado; Luis García-Ortiz
Journal:  BMJ Open       Date:  2014-04-03       Impact factor: 2.692

Review 4.  Missing Link between Molecular Aspects of Ventricular Arrhythmias and QRS Complex Morphology in Left Ventricular Hypertrophy.

Authors:  Ljuba Bacharova
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.